News

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...
GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...
GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...
GSK shares have risen 44p to 1476p after it reiterated full-year guidance and said it is “well positioned” to cope with the impact of any changes to US tariff rules. The reassurance came as GSK ...
GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule. Penmenvy was recommended to help ...
In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon. When investing, your capital is at risk.
MISSION TO MAKE EVERYONE BETTER BY THE MILE. TAKE A LOOK. THIS YEAR MARKS MATT BROWN’S 11TH BOSTON MARATHON, AND FOR THE FIRST TIME, HIS FOUNDATION IS A CHARITY. THE MATT BROWN FOUNDATION RAISES ...
Matt Shaw has not gotten off to a dream start in his rookie season for the Chicago Cubs. The team’s No. 1 prospect is batting just .170 with a .571 OPS and a 68 OPS+ through his first 47 MLB at ...
GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...